Globus Medical
GMED
610 hedge funds and large institutions have $9.43B invested in Globus Medical in 2026 Q1 according to their latest regulatory filings, with 108 funds opening new positions, 232 increasing their positions, 183 reducing their positions, and 54 closing their positions.
125% more call options, than puts
Call options by funds: $17.2M | Put options by funds: $7.64M
100% more first-time investments, than exits
New positions opened: 108 | Existing positions closed: 54
27% more repeat investments, than reductions
Existing positions increased: 232 | Existing positions reduced: 183
7% more funds holding
Funds holding: 568 → 610 (+42)
3% less capital invested
Capital invested by funds: $9.71B → $9.43B (-$279M)
2.04% less ownership
Funds ownership: 83.01% → 80.97% (-2%)
21% less funds holding in top 10
Funds holding in top 10: 24 → 19 (-5)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
+$126M |
| 2 |
Holocene Advisors
New York
|
+$69.5M |
| 3 |
AQR Capital Management
Greenwich,
Connecticut
|
+$65.4M |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
+$49.5M |
| 5 |
HRCM
Hawk Ridge Capital Management
Los Angeles,
California
|
+$44.9M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
MAP
Madison Avenue Partners
New York
|
-$171M |
| 2 |
Bank of Montreal
Toronto,
Ontario, Canada
|
-$95.7M |
| 3 |
PCM
Parsifal Capital Management
Greenwich,
Connecticut
|
-$75M |
| 4 |
Walleye Capital
New York
|
-$73.5M |
| 5 |
VPC
Vestal Point Capital
New York
|
-$59.6M |
GMED Hedge Fund Activity: Q1 2026 in Review
610 of the 8,208 institutional investors tracked by Wall St. Rank reported a position in Globus Medical (GMED) for Q1 2026, worth a combined $9.43B — down 2.9% from $9.71B a quarter earlier.
Buyers outnumbered sellers: 108 funds opened new GMED positions and 54 closed out — a net gain of 54 holders — while 232 added to existing stakes and 183 trimmed.
The largest buyer was Millennium Management, adding an estimated $126M. The largest seller was Madison Avenue Partners, cutting an estimated $171M.
- 610 institutional investors held Globus Medical (GMED) as of Q1 2026, up from 568 in Q4 2025.
- Funds reported $9.43B of Globus Medical stock for Q1 2026, down 2.9% quarter-over-quarter.
- 108 funds opened new Globus Medical positions in Q1 2026 and 54 closed out, a net change of +54 holders.
- The largest Globus Medical buyer in Q1 2026 was Millennium Management, an estimated $126M added.
- The largest Globus Medical seller in Q1 2026 was Madison Avenue Partners, an estimated $171M sold.
Based on aggregated 13F filings for Q1 2026.